Pfizer explores sale of hospital drugs unit, sources say
Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...
After a series of acquisitions and an activist investor’s accusation of overspending, Pfizer is exploring an opportunity to ...
Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.
Centessa had recently conducted an interim analysis of a phase 2 study of its drug, called SerpinPC, which is designed to ...
Pfizer's head of digital devices says the industry is close to a 'revolution' in using measures from wearables in clinical ...
Pfizer has a pill it's developing called danuglipron, which is in early-stage trials but has demonstrated that it's ...
Keurig Dr Pepper brings in Drew Panayiotou to accelerate digital marketing and Andrew Springate takes a new role.
We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...
Pfizer (PFE) is exploring the sale of its hospital drugs unit, now called Pfizer Hospital, which was formed after Pfizer bought Hospira for ...
Pfizer is reportedly considering selling one of its business units that has major operations in North Carolina STORY ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback